Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Janneke Wilschut"'
Autor:
Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui, Patricia Coelho De Soarez, Zakir Husain, John Hopper, Zia Sadique, Asima Mukhopadhyay, Li Yang, Johannes Berkhof, Rosa Legood
Publikováno v:
Cancers, Vol 12, Iss 7, p 1929 (2020)
Clinical criteria/Family history-based BRCA testing misses a large proportion of BRCA carriers who can benefit from screening/prevention. We estimate the cost-effectiveness of population-based BRCA testing in general population women across different
Externí odkaz:
https://doaj.org/article/8abf9ef457f243079f3da10713298439
Autor:
Janneke Wilschut, Marjolein van Ballegooijen, Ann G. Zauber, Iris Lansdorp-Vogelaar, Karen M. Kuntz, Amy B. Knudsen
Publikováno v:
Lansdorp-Vogelaar, I, Kuntz, K M, Knudsen, A B, Wilschut, J A, Zauber, A G & van Ballegooijen, M 2010, ' Stool DNA testing to screen for colorectal cancer in the Medicare population : a cost-effectiveness analysis ', Annals of Internal Medicine, vol. 153, no. 6, pp. 368-77 . https://doi.org/10.7326/0003-4819-153-6-201009210-00004
Annals of Internal Medicine, 153(6), 368-W124. American College of Physicians
Annals of Internal Medicine, 153(6), 368-77. American College of Physicians
Annals of Internal Medicine, 153(6), 368-W124. American College of Physicians
Annals of Internal Medicine, 153(6), 368-77. American College of Physicians
BACKGROUND: The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees.OBJECTIVE: To evaluate the conditions under which stool DNA testing could be cost-effe
Autor:
Amy B. Knudsen, Ann G. Zauber, Janneke Wilschut, Marjolein van Ballegooijen, Karen M. Kuntz, Iris Lansdorp-Vogelaar
Publikováno v:
Annals of Internal Medicine, 149(9), 659-+. American College of Physicians
Zauber, A G, Lansdorp-Vogelaar, I, Knudsen, A B, Wilschut, J, van Ballegooijen, M & Kuntz, K M 2008, ' Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the US Preventive Services Task Force ', Annals of Internal Medicine, vol. 149, no. 9, pp. 659-+ . https://doi.org/10.7326/0003-4819-149-9-200811040-00244
Zauber, A G, Lansdorp-Vogelaar, I, Knudsen, A B, Wilschut, J, van Ballegooijen, M & Kuntz, K M 2008, ' Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the US Preventive Services Task Force ', Annals of Internal Medicine, vol. 149, no. 9, pp. 659-+ . https://doi.org/10.7326/0003-4819-149-9-200811040-00244
Despite recent declines in both incidence and mortality (1), colorectal cancer remains the second most common cause of cancer death in the United States (2). Screening for colorectal cancer reduces mortality by allowing physicians to detect cancer at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6616056a05c8731607ff8536306705c
https://pure.eur.nl/en/publications/e5707bd2-ac37-4890-ac33-26b7df3a2dff
https://pure.eur.nl/en/publications/e5707bd2-ac37-4890-ac33-26b7df3a2dff